Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-07-08
2008-10-28
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S287000
Reexamination Certificate
active
07442704
ABSTRACT:
The invention concerns amide derivatives of Formula (Ia) wherein X is —NHCO— or —CONH—; m is 0-3; R1is a group such as hydroxy, halogeno, trifluoromethyl, cyano, mercapto, nitro, amino, carboxy and carbamoyl; n is 0-2; R2is a group such as hydroxy, halogeno, trifluoromethyl, cyano, mercapto, nitro, amino and carboxy; R3is hydrogen, halogeno, (1-6C)alkyl or (1-6C)alkoxy; q is 0-4; and Q is a group such as aryl, aryloxy, aryl-(1-6C)alkoxy, arylamino and N-(1-6C)alkyl-arylamino; or pharmaceutically-acceptable salts or in-vivo-cleavable esters thereof; processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of diseases or medical conditions mediated by cytokines.
REFERENCES:
patent: 1903899 (1933-04-01), Laska et al.
patent: 1909960 (1933-05-01), Hitch
patent: 3211555 (1965-10-01), Mory et al.
patent: 3755332 (1973-08-01), Wasley et al.
patent: 4367328 (1983-01-01), Bertram et al.
patent: 4524168 (1985-06-01), Wick
patent: 4749729 (1988-06-01), Kohli et al.
patent: 5710158 (1998-01-01), Myers et al.
patent: 6127374 (2000-10-01), Bridges
patent: 6432949 (2002-08-01), Brown et al.
patent: 6455520 (2002-09-01), Brown et al.
patent: 6465455 (2002-10-01), Brown et al.
patent: 6498274 (2002-12-01), Brown et al.
patent: 6548514 (2003-04-01), Brown
patent: 6579872 (2003-06-01), Brown et al.
patent: 6593333 (2003-07-01), Cumming
patent: 6686467 (2004-02-01), Brown et al.
patent: 6716847 (2004-04-01), Cumming
patent: 6784174 (2004-08-01), Cumming
patent: 6794380 (2004-09-01), Brown
patent: 6821965 (2004-11-01), Brown et al.
patent: 6846827 (2005-01-01), Cumming
patent: 6956037 (2005-10-01), Brown et al.
patent: 7008945 (2006-03-01), Brown
patent: 7060700 (2006-06-01), Brown et al.
patent: 522 788 (1931-03-01), None
patent: 28 12 252 (1979-10-01), None
patent: 0 566 226 (1993-10-01), None
patent: 0 635 507 (1995-01-01), None
patent: 0 849 256 (1998-06-01), None
patent: 0 945 443 (1999-09-01), None
patent: 61-204221 (1986-09-01), None
patent: 93/04170 (1993-03-01), None
patent: 95/19774 (1995-07-01), None
patent: 95/35304 (1995-12-01), None
patent: 97/05878 (1997-02-01), None
patent: 97/13771 (1997-04-01), None
patent: 97/32853 (1997-09-01), None
patent: 97/33883 (1997-09-01), None
patent: 98/06715 (1998-02-01), None
patent: 98/22103 (1998-05-01), None
patent: 99/01439 (1999-01-01), None
patent: 99/15164 (1999-04-01), None
patent: 99/59959 (1999-11-01), None
patent: 99/59960 (1999-11-01), None
patent: WO 99/59959 (1999-11-01), None
patent: 00/07980 (2000-02-01), None
patent: 00/07991 (2000-02-01), None
patent: 00/12485 (2000-03-01), None
patent: 00/12486 (2000-03-01), None
patent: 00/12487 (2000-03-01), None
patent: 00/18738 (2000-04-01), None
patent: 00/20402 (2000-04-01), None
patent: 00/55120 (2000-09-01), None
patent: 00/56738 (2000-09-01), None
patent: WO 00/55153 (2000-09-01), None
patent: 01/27089 (2001-04-01), None
patent: WO 02/083143 (2002-10-01), None
patent: WO 03/066603 (2003-08-01), None
patent: WO 2005/042502 (2005-05-01), None
U.S. Appl. No. 10/424,127, filed Apr. 28, 2003, Brown et al.
U.S. Appl. No. 10/947,463, filed Sep. 23, 2004, Brown et al.
U.S. Appl. No. 10/192,495, filed Jul. 11, 2002, Brown et al.
U.S. Appl. No. 11/125,321, filed May 10, 2005, Brown et al.
U.S. Appl. No. 09/936,758, filed Sep. 17, 2001, Brown.
Barakat et al. “Synthesis and Hypnotic Activity of Some New Quinazolinone Derivatives” Saudi Pharmaceutical Journal 3(3): 84-89 (1995).
Adams et al., “Search for trypanocides. III. Analogs of suramin.”, Chemical Abstracts, vol. 51, 1957, columns 5068 and 5069.
Ando et al., “Producing azo lake pigments”; Chemical Abstract, vol. 106, Abstract No. 215574.
Ando et al., “Substitutent Shielding Parameters of Ffluorine-19 NMR on Polyfluoroaromatic Compounds Dissolved in Dimethyl Sulfoxide-d6”, Magn. Reson.Chem. 639-45, 1995, Chemical Abstract: 123: 227514, 1995.
Ashton et al., “New Low-Density Lipoprotein Receptor Upregulators Acting via a Novel Mechanism”, J. Med. Chem., 1996, vol. 39, pp. 3343-3356.
Beilstein Reg. No. 2164595.
Beilstein Reg. No. 3166971.
Beilstein Reg. No. 3451759.
Beilstein Reg. No. 3480574.
Beilstein Reg. No. 3483669.
Beilstein Reg. No. 3534091.
Chemical Abstract No. 12076g, vol. 65, 1966.
Chemical Abstract No. 12932a, vol. 51, 1957.
Denny et al. “Potential Antitumor Agents. 29. Quantitative Structure-Activity Relationships for the Antileukemic Bisquaternary Ammonium Heterocycles”, Journal of Medicinal Chemistry, Feb. 1979, vol. 22, No. 2, pp. 134-150.
Hamuro et al., “Novel Folding Patterns in a Family of Oligoanthranilamides . . . Secondary Structures”, J. Amer. Chem. Soc., 1997, pp. 10587-10593.
Ito et al., Photosensitive material containing microencapsulated hydrazine derivatives; Chemical Abstract, vol. 118, Abstract No. 70021.
Kelley et al., “Antirhinovirus Activity of 6-Anilino-9-benxyl-2-chloro-9H-purines”, J. Med. Chem., 1990, vol. 33, pp. 1360-1363, XP-002140324.
Kuboto et al.; Abstract No. 84:45269, Japan 50105558, Aug. 1975.
Lesiak, “New amides of pyrrole-N- and indole-N-caboxylic acids”, Chemical Abstracts, No. 126704v, XP-002121335.
Makoto; “Amide and Its Use”; Patent Abstracts of Japan, Abstract No. 09124571, May 13, 1997, also attached: Abstract (Derwent); XP 002086154.
Mühlbach, “Pyrazoles—A Novel Class of Blocking Agents for Isocyanates”, Journal of Polymer Science: Part A: Polymer Chemistry, vol. 32, Mar. 1994, pp. 753-765.
Myers et al., “The Preparation of SAR of 4-(Anilino), 4-(Phenoxy), and 4- (Thiophenoxy)-Quinazoline: Inhibitors of P56lckand EGF-R Tyrosine Kinase Activity”, Bioorganic & Medicinal Chemistry Letters, vol. 7, No. 4, pp. 417-420.
Petrova et al., “Determination of the Structure of the Oxidative . . . by Spectroscopic Methods”, Journal of Molecular Structure, vol. 142, 1986, pp. 459-462.
Sugawara et al., Kogyo Kaguku Zasshi 72(11) 2425-2429, 1969, Chemical Abstract: 72:66514, 1970.
Thompson et al., “Tyrosine Kinase Inhibitors. 7.7-Amino-4-(phenylamino- and 7-Amino-4-[(phenylmethyl)amino]purido[4,3-d[pyrimidines: A New Class of Inhibitors of the Tyrosine Kinase Activity of the Epidermal Growth Factor Receptor”; Journal of Medicinal Chemistry, US, American Chemical Society, vol. 39, No. 19, 1995, pp. 3780-3788, XP002140323.
Wang et al., “Low-valent Titanium-induced Reactions of Substituted Nitrobenzenes”, J. Chem. Research, 1998, pp. 182-183.
Chemical Abstracts, vol. 77, No. 3, Jul. 17, 1972, Abstract No. 019599, Kozhevnikov, “Syntheiss of nitro and amino derivatives of 2-methyl-3-aryl-4-quinazolone”, XP002139275 cited in the application abstract & Izv. Vyssh. Ucheb. Zaved., Khim. Khim. Tekhnol. (IVUKAR): 1971; vol. 14 (11), pp. 1685-1689, Perm. Farm. Inst.; Perm; USSR.
Chemical Abstracts, vol. 069, No. 15, Oct. 7, 1968, Abstract No. 059182, Parmar, S., et al., “Synthesis of substituted quinazoline hydrazides: the relation between chemical structure and monoamine oxidase inhibitor activity”, XP002138276, Abstract & Can. J. Chem. (CJCHAG); 1968; vol. 46 (15), pp. 2519-2524, Lucknow Univ.; King George's Med. Coll.; Lucknow; India.
AstraZeneca AB
Morgan & Lewis & Bockius, LLP
Saeed Kamal A
LandOfFree
Amide derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amide derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amide derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3990141